Premium
Use of local anesthetic (0.25% bupivacaine) for pain control after pediatric cardiac catheterization: A randomized controlled trial
Author(s) -
Palma Amy,
Viegas Jacqueline,
Manlhiot Cedric,
McCrindle Brian,
Benson Lee
Publication year - 2015
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.26284
Subject(s) - medicine , bupivacaine , anesthesia , local anesthetic , randomized controlled trial , cardiac catheterization , analgesic , surgery , anesthetic , morphine
Objectives To investigate the effects of local infiltration of 0.25% bupivacaine on post‐operative pain and analgesic use in children undergoing cardiac catheterization procedures. Background In pediatric catheterization procedures performed under general anesthesia, a local anesthetic is often used prior to femoral sheath removal. There are no published reports of the impact of local anesthetic infiltration on pain after pediatric procedures, and mixed reports on its effectiveness in adults. Methods A randomized controlled trial was undertaken of 140 children, aged 7–18 years undergoing cardiac catheterization under general anesthesia via the femoral vein or artery. Participants received a subcutaneous infiltration of 0.25% bupivacaine at the access site prior to sheath removal, or usual care without bupivacaine. Outcomes included patient reported pain scores and analgesic use up to 6 hr after the procedure. Results Pain scores were similar between groups through the 6‐hr post‐procedure period. The proportion of children reporting a maximal pain score of ≤2/10 was higher in the bupivacaine group (64% vs. 44%, P = 0.03). A significantly higher proportion of children in the control group required IV morphine (18.8% vs. 4.5%, P = 0.02). Conclusions Morphine use can be reduced with the use of 0.25% bupivacaine given prior to femoral sheath removal and should be considered for post‐procedural pain control for pediatric patients undergoing cardiac catheterization. This study is the first to contribute evidence to the effectiveness of 0.25% bupivacaine after pediatric cardiac catheterization. © 2015 Wiley Periodicals, Inc.